These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9616195)

  • 1. Pharmacokinetics of meloxicam in animals and the relevance to humans.
    Busch U; Schmid J; Heinzel G; Schmaus H; Baierl J; Huber C; Roth W
    Drug Metab Dispos; 1998 Jun; 26(6):576-84. PubMed ID: 9616195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of meloxicam.
    Türck D; Busch U; Heinzel G; Narjes H
    Arzneimittelforschung; 1997 Mar; 47(3):253-8. PubMed ID: 9105543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excretion mass balance evaluation, metabolite profile analysis and metabolite identification in plasma and excreta after oral administration of [14C]-meloxicam to the male cat: preliminary study.
    Grudé P; Guittard J; Garcia C; Daoulas I; Thoulon F; Ebner T
    J Vet Pharmacol Ther; 2010 Aug; 33(4):396-407. PubMed ID: 20646203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meloxicam pharmacokinetics using nonlinear mixed-effects modeling in ferrets after single subcutaneous administration.
    Chinnadurai SK; Messenger KM; Papich MG; Harms CA
    J Vet Pharmacol Ther; 2014 Aug; 37(4):382-7. PubMed ID: 24483951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of Single-dose Subcutaneous Meloxicam Injections in Black-tailed Prairie Dogs (
    Wright TL; Eshar D; McCullough C; Warner M; Kukanich B
    J Am Assoc Lab Anim Sci; 2017 Sep; 56(5):539-543. PubMed ID: 28903825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of a Single Dose of Oral and Subcutaneous Meloxicam in Caribbean Flamingos ( Phoenicopterus ruber ruber).
    Lindemann DM; Carpenter JW; KuKanich B
    J Avian Med Surg; 2016 Mar; 30(1):14-22. PubMed ID: 27088740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of meloxicam in piglets.
    Fosse TK; Haga HA; Hormazabal V; Haugejorden G; Horsberg TE; Ranheim B
    J Vet Pharmacol Ther; 2008 Jun; 31(3):246-52. PubMed ID: 18471146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects.
    Schmid J; Busch U; Heinzel G; Bozler G; Kaschke S; Kummer M
    Drug Metab Dispos; 1995 Nov; 23(11):1206-13. PubMed ID: 8591720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacodynamic and pharmacokinetic aspects of the non-inflammatory non-steroidal agent meloxicam in dogs].
    Poulsen Nautrup B; Hörstermann D
    Dtsch Tierarztl Wochenschr; 1999 Mar; 106(3):94-100. PubMed ID: 10220944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the clinical pharmacokinetics of meloxicam.
    Türck D; Roth W; Busch U
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():13-6. PubMed ID: 8630630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of inflammation on kidney function and pharmacokinetics of COX-2 selective nonsteroidal anti-inflammatory drugs rofecoxib and meloxicam.
    Harirforoosh S; Jamali F
    J Appl Toxicol; 2008 Oct; 28(7):829-38. PubMed ID: 18344196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving solubility and pharmacokinetics of meloxicam via multiple-component crystal formation.
    Weyna DR; Cheney ML; Shan N; Hanna M; Zaworotko MJ; Sava V; Song S; Sanchez-Ramos JR
    Mol Pharm; 2012 Jul; 9(7):2094-102. PubMed ID: 22642304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic Profiles of Meloxicam and Sustained-release Buprenorphine in Prairie Dogs (
    Cary CD; Lukovsky-Akhsanov NL; Gallardo-Romero NF; Tansey CM; Ostergaard SD; Taylor WD; Morgan CN; Powell N; Lathrop GW; Hutson CL
    J Am Assoc Lab Anim Sci; 2017 Mar; 56(2):160-165. PubMed ID: 28315645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meloxicam: metabolic profile and biotransformation products in the rat.
    Schmid J; Busch U; Trummlitz G; Prox A; Kaschke S; Wachsmuth H
    Xenobiotica; 1995 Nov; 25(11):1219-36. PubMed ID: 8592871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
    J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meloxicam in racing greyhounds.
    Gower S
    Vet Rec; 2018 May; 182(18):518. PubMed ID: 29728485
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of pharmacokinetic interaction of meloxicam with methotrexate in patients with rheumatoid arthritis.
    Hübner G; Sander O; Degner FL; Türck D; Rau R
    J Rheumatol; 1997 May; 24(5):845-51. PubMed ID: 9150070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interspecies difference of luteolin and apigenin after oral administration of Chrysanthemum morifolium extract and prediction of human pharmacokinetics.
    Li LP; Wu XD; Chen ZJ; Sun SY; Ye JF; Zeng S; Jiang HD
    Pharmazie; 2013 Mar; 68(3):195-200. PubMed ID: 23556338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of human cytochrome P-450 3A4-catalyzed meloxicam 5'-methylhydroxylation by quinidine and hydroquinidine in vitro.
    Ludwig E; Schmid J; Beschke K; Ebner T
    J Pharmacol Exp Ther; 1999 Jul; 290(1):1-8. PubMed ID: 10381752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.